Skip to main content

Advertisement

SpringerLink
Log in

Temporal Trends of Ovarian Cancer Between 1990 and 2019, in Asian Countries by Geographical Region and SDI, Comparison with Global Data

  • Original Article
  • Published:
Indian Journal of Gynecologic Oncology Aims and scope Submit manuscript

Abstract

Aim

Ovarian cancer is one of the health challenges all across the world, which causes significant burden and mortality in women. With the fastest-growing population, Asia has one of the largest populations in the world, and considerable variation in health statistics can be seen in this continent. So this study was conducted to investigate temporal trends of ovarian cancer in Asian countries between 1999 and 2019.

Methods and Materials

We collected ovarian cancer data from the 2019 Global Burden of Disease study from 1990 to 2019 in 49 Asian countries and territories. Annual case data and age-standardized rates (ASRs) were used to investigate the incidence, prevalence, mortality, and disability-adjusted life-years (DALYs) of OC from 1990 to 2019 in 49 Asian countries and territories. Relative difference (%) between years was used to show the comparative changes in the selected indicators’ age-standardized rates.

Results

In Asia, with more than half of the world’s population there is significant diversity in the incidence, prevalence, mortality, and burden of cancer. The number of ovarian cancer cases increased by 3.4 times during 1990–2019 and the ASR increased by 60%. With a 3.4-fold increase in mortality from 1990 to 2019, 47% of ovarian cancer deaths in 2019 occurred in Asian countries. Although during the years 1990–2019, the age-standardized DALYs rate in the world was in a stable state without significant changes, Asian countries experienced a 42% change. The highest incidence, prevalence, mortality, and burden of disease belonged to Brunei Darussalam, Brunei Darussalam, Pakistan, and Pakistan, respectively, and the lowest in all 4 categories was related to Yemen.

Conclusion

While the world is experiencing a decreasing trend in the death rate caused by ovarian cancer, in Asia only High-income Asia Pacific countries are witnessing a decreasing trend, and the rate of increase in incidence and prevalence is also higher in Asia than in the world. Therefore, it seems that improving the awareness of women in the field of ovarian cancer and implementing effective strategies for early detection can reduce the epidemiological indicators of ovarian cancer in Asia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Allahqoli L, Mazidi Moradi A, Momenimovahed Z, Rahmani A, Hakimi S, Tiznobaik A, et al. The global incidence, mortality, and burden of breast cancer in 2019: correlation with smoking, drinking, and drug use. Front Oncol. 2022;12:921015–921015.

    PubMed  PubMed Central  Google Scholar 

  2. Doherty JA, Peres LC, Wang C, Way GP, Greene CS, Schildkraut JM. Challenges and opportunities in studying the epidemiology of ovarian cancer subtypes. Curr Epidemiol Rep. 2017;4(3):211–20.

    PubMed  PubMed Central  Google Scholar 

  3. Hwang JY-F, Lim W-Y, Tan CS, Lim SL, Chia J, Chow KY, et al. Ovarian cancer incidence in the multi-ethnic Asian City-State of Singapore 1968–2012. Asian Pac J Cancer Prev APJCP. 2019;20(12):3563.

    PubMed  Google Scholar 

  4. Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019;11:287–99.

    PubMed  PubMed Central  Google Scholar 

  5. Rizzuto I, Stavraka C, Chatterjee J, Borley J, Hopkins TG, Gabra H, et al. Risk of ovarian cancer relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancer. Int J Gynecol Cancer. 2015. https://doi.org/10.1097/IGC.0000000000000361.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Chornokur G, Amankwah EK, Schildkraut JM, Phelan CM. Global ovarian cancer health disparities. Gynecol Oncol. 2013;129(1):258–64.

    PubMed  Google Scholar 

  7. Shabir S, Gill PK. Global scenario on ovarian cancer–Its dynamics, relative survival, treatment, and epidemiology. Adesh Univ J Med Sci Res. 2020;2(1):17–25.

    Google Scholar 

  8. Ghoncheh M, Mohammadian M, Mohammadian-Hafshejani A, Salehiniya H. The incidence and mortality of colorectal cancer and its relationship with the human development index in Asia. Ann Glob Health. 2014;82(5):726–37.

    Google Scholar 

  9. Tew WP. Ovarian cancer in the older woman. J Geriatr Oncol. 2016;7(5):354–61.

    PubMed  Google Scholar 

  10. Balachandran A, de Beer J, James KS, van Wissen L, Janssen F. Comparison of population aging in Europe and Asia using a time-consistent and comparative aging measure. J Aging Health. 2020;32(5–6):340–51.

    PubMed  Google Scholar 

  11. Yap MT, Thang LL, Traphagan JW. Introduction: aging in Asia–perennial concerns on support and caring for the old. J Cross Cult Gerontol. 2005;20(4):257–67.

    PubMed  Google Scholar 

  12. Goh VH. Aging in Asia: a cultural, socio-economical and historical perspective. Aging Male Off J Int Soc Study Aging Male. 2005;8(2):90–6.

    Google Scholar 

  13. Mubarik S, Wang F, Fawad M, Wang Y, Ahmad I, Yu C. Trends and projections in breast cancer mortality among four Asian countries (1990–2017): evidence from five stochastic mortality models. Sci Rep. 2020;10(1):5480.

    PubMed  PubMed Central  Google Scholar 

  14. Ning F-L, Lyu J, Pei J-P, Gu W-J, Zhang N-N, Cao S-Y, et al. The burden and trend of gastric cancer and possible risk factors in five Asian countries from 1990 to 2019. Sci Rep. 2022;12(1):5980.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–22.

    Google Scholar 

  16. Collaboration GBoDC. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2022;8(3):420–44.

    Google Scholar 

  17. Sharma R, Abbasi-Kangevari M, Abd-Rabu R, Abidi H, Abu-Gharbieh E, Acuna JM, et al. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol. 2022;7(7):627–47.

    Google Scholar 

  18. Go DS, Kim YE, Yoon SJ. Subnational burden of disease according to the sociodemographic index in South Korea. Int J Environ Res Public Health. 2020;17(16):5788.

    PubMed  PubMed Central  Google Scholar 

  19. Fan J, Liu Z, Mao X, Tong X, Zhang T, Suo C, et al. Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017. Cancer Med. 2020;9(18):e03338.

    PubMed  PubMed Central  Google Scholar 

  20. Evaluation IfHMa. Protocol for the global burden of diseases, injuries, and risk factors study (GBD) Version 4.0. Global burden of diseases, injuries, and risk factors study; 2020.

  21. Liede A, Narod SA. Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat. 2002;20(6):413–24.

    CAS  PubMed  Google Scholar 

  22. Park S, Bae J, Nam B-H, Yoo K-Y. Aetiology of cancer in Asia. Asian Pac J Cancer Prev. 2008;9(3):371–80.

    PubMed  Google Scholar 

  23. Razi S, Ghoncheh M, Mohammadian-Hafshejani A, Aziznejhad H, Mohammadian M, Salehiniya H. The incidence and mortality of ovarian cancer and their relationship with the human development index in Asia. Ecancermedicalscience. 2016;10:628.

    PubMed  PubMed Central  Google Scholar 

  24. Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Women’s Health. 2019;11:287.

    Google Scholar 

  25. Wang J, Lv H, Xue Z, Wang L, Bai Z. Temporal trends of common female Malignances on breast, cervical, and ovarian cancer Mortality in Japan, Republic of Korea, and Singapore: application of the age-period-cohort model. Biomed Res Int. 2018;2018:5307459.

    PubMed  PubMed Central  Google Scholar 

  26. Gharwan H, Bunch KP, Annunziata CM. The role of reproductive hormones in epithelial ovarian carcinogenesis. Endocr Relat Cancer. 2015;22(6):R339–63.

    CAS  PubMed  Google Scholar 

  27. Hwang JY, Lim WY, Tan CS, Lim SL, Chia J, Chow KY, et al. Ovarian cancer incidence in the multi-ethnic Asian City-State of Singapore 1968–2012. Asian Pac J Cancer Prev. 2019;20(12):3563–9.

    PubMed  PubMed Central  Google Scholar 

  28. Terplan M, Schluterman N, McNamara EJ, Tracy JK, Temkin SM. Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. Gynecol Oncol. 2012;125(1):19–24.

    PubMed  Google Scholar 

  29. Matz M, Coleman MP, Carreira H, Salmerón D, Chirlaque MD, Allemani C, et al. Worldwide comparison of ovarian cancer survival: histological group and stage at diagnosis (CONCORD-2). Gynecol Oncol. 2017;144(2):396–404.

    PubMed  Google Scholar 

  30. Giri SK, Nayak B. Management of ovarian cancer in Elderly. Rev Recent Clin Trials. 2015;10(4):270–5.

    PubMed  Google Scholar 

  31. Norquist BM, Harrell MI, Brady MF, Walsh T, Lee MK, Gulsuner S, et al. Inherited mutations in women with ovarian carcinoma. JAMA Oncol. 2016;2(4):482–90.

    PubMed  PubMed Central  Google Scholar 

  32. McKnight KK, Wellons MF, Sites CK, Roth DL, Szychowski JM, Halanych JH, et al. Racial and regional differences in age at menopause in the United States: findings from the reasons for geographic and racial differences in stroke (REGARDS) study. Am J obstet Gynecol. 2011;205(4):353.

    PubMed Central  Google Scholar 

  33. Richard-Davis G, Wellons M, editors. Racial and ethnic differences in the physiology and clinical symptoms of menopause. Seminars in reproductive medicine. New York: Thieme Medical Publishers; 2013.

    Google Scholar 

  34. Peres LC, Risch H, Terry KL, Webb PM, Goodman MT, Wu AH, et al. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol. 2018;47(2):460–72.

    PubMed  Google Scholar 

  35. Zhou B, Sun Q, Cong R, Gu H, Tang N, Yang L, et al. Hormone replacement therapy and ovarian cancer risk: a meta-analysis. Gynecol Oncol. 2008;108(3):641–51.

    CAS  PubMed  Google Scholar 

  36. Li L, Ji J, Wang J-b, Niyazi M, Qiao Y-l, Boffetta P. Attributable causes of breast cancer and ovarian cancer in China: reproductive factors, oral contraceptives and hormone replacement therapy. Chin J Cancer Res. 2012;24(1):9–17.

    PubMed  PubMed Central  Google Scholar 

  37. Tabassum S, Masood AI, Khakwani M. Pattern of female gynecological malignancies in south Punjab Region of Pakistan: an overview of 5 years. Prof Med J. 2021;28(01):90–5.

    Google Scholar 

  38. He R, Zhu B, Liu J, Zhang N, Zhang W-H, Mao Y. Women’s cancers in China: a spatio-temporal epidemiology analysis. BMC Womens Health. 2021;21(1):116.

    PubMed  PubMed Central  Google Scholar 

  39. Leong E, Ong SK, Jali F, Naing L. Incidence, mortality and survival analysis of epithelial ovarian cancer in Brunei Darussalam. Asian Pac J Cancer Prev APJCP. 2022;23(4):1415.

    PubMed  Google Scholar 

  40. Sankaranarayanan R, Ramadas K, Qiao YL. Managing the changing burden of cancer in Asia. BMC Med. 2014;12:3.

    PubMed  PubMed Central  Google Scholar 

  41. Siddiqui AH, Zafar SN. Global availability of cancer registry data. J Glob Oncol. 2018;4:1–3.

    PubMed  Google Scholar 

  42. Zheng L, Cui C, Shi O, Lu X, Li Y-K, Wang W, et al. Incidence and mortality of ovarian cancer at the global, regional, and national levels, 1990–2017. Gynecol Oncol. 2020;159(1):239–47.

    PubMed  Google Scholar 

  43. Shanmughapriya S, Nachiappan V, Natarajaseenivasan K. BRCA1 and BRCA2 mutations in the ovarian cancer population across race and ethnicity: special reference to Asia. Oncology. 2013;84(4):226–32.

    CAS  PubMed  Google Scholar 

  44. Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14(1):9.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clini. 2019;69(4):280–304.

    Google Scholar 

  46. Havrilesky LJ, Moorman PG, Lowery WJ, Gierisch JM, Coeytaux RR, Urrutia RP, et al. Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis. Obstet Gynecol. 2013;122(1):139–47.

    CAS  PubMed  Google Scholar 

  47. Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst. 2013;105(11):812–22.

    CAS  PubMed  Google Scholar 

  48. Lee J-Y, Kim E-Y, Jung K-W, Shin A, Chan KKL, Aoki D, et al. Trends in gynecologic cancer mortality in East Asian regions. jgo. 2014;25(3):174–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  49. Najafi-Sharjabad F, Zainiyah Syed Yahya S, Abdul Rahman H, Hanafiah Juni M, Abdul MR. Barriers of modern contraceptive practices among Asian women: a mini literature review. Glob J Health Sci. 2013;5(5):181–92.

    PubMed  PubMed Central  Google Scholar 

  50. Stewart C, Ralyea C, Lockwood S. Ovarian cancer: an integrated review. Semin Oncol Nurs. 2019;35(2):151–6.

    PubMed  Google Scholar 

  51. Low EL, Waller J, Menon U, Jones A, Reid F, Simon AE. Ovarian cancer symptom awareness and anticipated time to help-seeking for symptoms among UK women. J Fam Plan Reprod Health Care. 2013;39(3):163–71.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Qom University of Medical Sciences, Qom, Iran

    Zohre Momenimovahed

  2. Shiraz University of Medical Sciences, Shiraz, Iran

    Afrooz Mazidimoradi

  3. Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

    Niloofar Banakar

  4. Ministry of Health and Medical Education, Tehran, Iran

    Leila Allahqoli

  5. Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran

    Hamid Salehiniya

Authors
  1. Zohre Momenimovahed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Afrooz Mazidimoradi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Niloofar Banakar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Leila Allahqoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hamid Salehiniya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hamid Salehiniya.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOC 2033 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Momenimovahed, Z., Mazidimoradi, A., Banakar, N. et al. Temporal Trends of Ovarian Cancer Between 1990 and 2019, in Asian Countries by Geographical Region and SDI, Comparison with Global Data. Indian J Gynecol Oncolog 21, 38 (2023). https://doi.org/10.1007/s40944-023-00714-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40944-023-00714-8

Keywords

Search

Navigation